HHS released the data earlier this week, which makes it the first time anyone can review the information on the ownership of more than 6,000 hospices and 11,000 home health agencies.
Some of the data available to the public includes: enrollment information such as organization name, type, practice location addresses, National Provider Identifier (NPI), and CMS Certification Number (CCN).
© j-mel - stock.adobe.com
Ownership data for all Medicare-certified hospice and home health agencies has become available to the public as the Biden-Harris Administration’s initiative to increase transparency, protect consumers and promote competition within the industry.
The U.S. Department of Health and Human Services (HHS) released the data earlier this week which makes it the first time anyone can review the information of the ownership of more than 6,000 hospices and 11,000 home health agencies. This information is available on the Centers for Medicare & Medicaid Services (CMS) website.
According to a release by the HHS, data available to the public includes: enrollment information such as organization name, type, practice location addresses, National Provider Identifier (NPI), and CMS Certification Number (CCN); detailed information about each owner such as whether it’s an organization or an individual and whether it’s a direct owner or indirect owner; and a numerical associate ID for each owner to enable linkage to the enrollment file.
Additional information includes data on mergers, acquisitions, consolidations, and changes of ownership since 2016 for hospices and home health agencies enrolled in Medicare.
“It’s plain and simple: families deserve transparency when making decisions about hospice and home health care for their loved ones,” said HHS Secretary Xavier Becerra in the release. “President Biden has called for unprecedented action to increase transparency – and we are making more data publicly available than ever before. Shining a light on ownership data is good for families, good for researchers, and good for enforcement agencies. We will continue delivering on the President’s directive to promote competition and protect consumers.”
This recent effort is just another in the few that CMS has made in the last year. For example:
Making ownership information transparent benefits researchers and enforcement agencies by allowing them to identify common owners that have had histories of poor performance, analyze data and trends on how market consolidation impacts consumers with increased costs without improving quality of care, and evaluate the relationships between ownership and changes in healthcare costs and outcomes, according to the release.
As far as how it benefits the public, this data can assist patients and their loved ones in making more informed decisions about care.
Matt Eyles, President and CEO of AHIP, seconds that this effort will improve access to affordable, high-quality care.
“Every American deserves access to affordable, high-quality care, including the tens of millions of seniors and people with disabilities who have Medicare coverage,” Eyles said in a statement. “Research has shown that private equity purchases of certain specialty physicians is driving up health care costs for American families. That is why we support HHS’ transparency into the ownership of more than 6,000 hospice and 11,000 home health agencies. Such market-based policies and solutions are the right approach to improving competition, which is so essential to improving affordability, access, and value.”
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More